These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22983827)

  • 21. Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy.
    Liu L; Yuan P; Wu C; Zhang X; Wang F; Guo H; Zhong R; Xu Y; Wu J; Yu D; Wu T; Zhang X; Nie S; Miao X; Lin D
    Lung Cancer; 2011 Jul; 73(1):110-5. PubMed ID: 21129812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of XRCC1 Codon399 polymorphisms in Chinese patients with locally advanced nasopharyngeal carcinoma treated with radiation therapy.
    Zhai XM; Hu QC; Gu K; Wang JP; Zhang JN; Wu YW
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e125-32. PubMed ID: 23910235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Updated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population.
    Yang HY; Yang SY; Shao FY; Wang HY; Wang YD
    Asian Pac J Cancer Prev; 2015; 16(2):495-500. PubMed ID: 25684477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of XRCC1 gene polymorphisms in non-small cell lung cancer cisplatin-based chemotherapy, and their effect on clinical and pathological characteristics.
    Liu HF; Liu JS; Deng JH; Wu RR
    Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28081275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphisms of XRCC1, alcohol consumption, and the risk of colorectal cancer in Japan.
    Yin G; Morita M; Ohnaka K; Toyomura K; Hamajima N; Mizoue T; Ueki T; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Yasunami Y; Maekawa T; Takenaka K; Ichimiya H; Terasaka R
    J Epidemiol; 2012; 22(1):64-71. PubMed ID: 22186158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation of the sensitivity of NP chemotherapy in non-small lung cancer with DNA repair gene XRCC1 polymorphism].
    Hong CY; Xu Q; Yue Z; Zhang Y; Yuan Y
    Ai Zheng; 2009 Dec; 28(12):1291-7. PubMed ID: 19958624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease.
    Trabulus S; Guven GS; Altiparmak MR; Batar B; Tun O; Yalin AS; Tunckale A; Guven M
    Mol Biol Rep; 2012 Jun; 39(6):6995-7001. PubMed ID: 22302399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of the Arg194Trp and the Arg399Gln polymorphisms of the XRCC1 gene with risk occurrence and the response to adjuvant therapy among Polish women with breast cancer.
    Przybylowska-Sygut K; Stanczyk M; Kusinska R; Kordek R; Majsterek I
    Clin Breast Cancer; 2013 Feb; 13(1):61-8. PubMed ID: 23103366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphism in XRCC1 gene modulates survival and clinical outcomes of advanced North Indian lung cancer patients treated with platinum-based doublet chemotherapy.
    Singh A; Singh N; Behera D; Sharma S
    Med Oncol; 2017 Apr; 34(4):64. PubMed ID: 28332164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in genes of APE1, PARP1, and XRCC1: risk and prognosis of colorectal cancer in a northeast Chinese population.
    Li Y; Li S; Wu Z; Hu F; Zhu L; Zhao X; Cui B; Dong X; Tian S; Wang F; Zhao Y
    Med Oncol; 2013 Jun; 30(2):505. PubMed ID: 23430444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma.
    Cheng XD; Lu WG; Ye F; Wan XY; Xie X
    J Exp Clin Cancer Res; 2009 Jun; 28(1):91. PubMed ID: 19563645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt.
    Abdel-Rahman SZ; Soliman AS; Bondy ML; Omar S; El-Badawy SA; Khaled HM; Seifeldin IA; Levin B
    Cancer Lett; 2000 Oct; 159(1):79-86. PubMed ID: 10974409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms in XRCC1, APE1, ADPRT, XRCC2, and XRCC3 and risk of chronic benzene poisoning in a Chinese occupational population.
    Zhang Z; Wan J; Jin X; Jin T; Shen H; Lu D; Xia Z
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2614-9. PubMed ID: 16284386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine diphosphate ribosyl transferase and x-ray repair cross-complementing 1 polymorphisms in gastric cardia cancer.
    Miao X; Zhang X; Zhang L; Guo Y; Hao B; Tan W; He F; Lin D
    Gastroenterology; 2006 Aug; 131(2):420-7. PubMed ID: 16890595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population.
    Wang Z; Xu B; Lin D; Tan W; Leaw S; Hong X; Hu X
    Lung Cancer; 2008 Oct; 62(1):99-104. PubMed ID: 18400332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 in the survival of colorectal cancer receiving chemotherapy in the Chinese population.
    Liu Y; Chen H; Chen L; Hu C
    Hepatogastroenterology; 2012 Jun; 59(116):977-80. PubMed ID: 22580644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians.
    Natukula K; Jamil K; Pingali UR; Attili VS; Madireddy UR
    Asian Pac J Cancer Prev; 2013; 14(9):5275-9. PubMed ID: 24175813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of satraplatin and prednisone in patients with metastatic castration-resistant prostate cancer: a pharmacogenetic assessment of outcome and toxicity.
    Figg WD; Chau CH; Madan RA; Gulley JL; Gao R; Sissung TM; Spencer S; Beatson M; Aragon-Ching J; Steinberg SM; Dahut WL
    Clin Genitourin Cancer; 2013 Sep; 11(3):229-37. PubMed ID: 23684781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implication of polymorphisms in DNA repair genes in prognosis of hepatocellular carcinoma.
    Yue AM; Xie ZB; Guo SP; Wei QD; Yang XW
    Asian Pac J Cancer Prev; 2013; 14(1):355-8. PubMed ID: 23534753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.
    Chiang CI; Huang YL; Chen WJ; Shiue HS; Huang CY; Pu YS; Lin YC; Hsueh YM
    Toxicol Appl Pharmacol; 2014 Sep; 279(3):373-379. PubMed ID: 25018058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.